Continuous glucose monitoring: A cost‐effective tool to reduce pre‐term birth rates in women with type one diabetes

Abstract

CGM use in pregnancy is a cost-effective intervention for reducing the risk of pre-term birth in women with type one diabetes, resulting in a net cost benefit to the health sector.